BR112016026143A2 - os métodos e composições compreendendo ácido 10-hidroxi-2-decenóico. - Google Patents

os métodos e composições compreendendo ácido 10-hidroxi-2-decenóico.

Info

Publication number
BR112016026143A2
BR112016026143A2 BR112016026143A BR112016026143A BR112016026143A2 BR 112016026143 A2 BR112016026143 A2 BR 112016026143A2 BR 112016026143 A BR112016026143 A BR 112016026143A BR 112016026143 A BR112016026143 A BR 112016026143A BR 112016026143 A2 BR112016026143 A2 BR 112016026143A2
Authority
BR
Brazil
Prior art keywords
hydroxy
compositions
methods
decenoic acid
decenoic
Prior art date
Application number
BR112016026143A
Other languages
English (en)
Inventor
Butt Christopher
Weiser Michael
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BR112016026143A2 publication Critical patent/BR112016026143A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
BR112016026143A 2014-05-08 2015-05-07 os métodos e composições compreendendo ácido 10-hidroxi-2-decenóico. BR112016026143A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461990283P 2014-05-08 2014-05-08
PCT/US2015/029790 WO2015171960A1 (en) 2014-05-08 2015-05-07 Methods and compositions comprising 10-hydroxy-2-decenoic acid

Publications (1)

Publication Number Publication Date
BR112016026143A2 true BR112016026143A2 (pt) 2018-08-07

Family

ID=54393026

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016026143A BR112016026143A2 (pt) 2014-05-08 2015-05-07 os métodos e composições compreendendo ácido 10-hidroxi-2-decenóico.

Country Status (8)

Country Link
US (1) US10004711B2 (pt)
EP (1) EP3139741A4 (pt)
JP (1) JP6819957B2 (pt)
KR (1) KR102399290B1 (pt)
CN (1) CN106470547B (pt)
BR (1) BR112016026143A2 (pt)
TW (1) TWI743022B (pt)
WO (1) WO2015171960A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197840B2 (en) * 2015-12-04 2021-12-14 Wah Chin BOON Methods of treating or alleviating mental disorders and associated symptoms
WO2019195658A1 (en) 2018-04-05 2019-10-10 Dana-Farber Cancer Institute, Inc. Sting levels as a biomarker for cancer immunotherapy
CN108310026A (zh) * 2018-04-28 2018-07-24 宁夏医科大学 月见草油在改善多囊卵巢综合征慢性炎症方面的应用
JP7240714B2 (ja) * 2019-01-24 2023-03-16 株式会社山田養蜂場本社 γヒドロキシ酪酸受容体結合剤
CN110916088A (zh) * 2019-11-04 2020-03-27 齐鲁工业大学 一种适合炎性肠病人群的全营养特医食品及制备方法
CN112094790B (zh) * 2020-11-17 2021-03-02 河北一然生物科技有限公司 一种调节肠道菌群的植物乳杆菌lp45活菌制剂及应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1033843A (en) 1964-05-26 1966-06-22 Eustace Cecil Barton Wright Pharmaceutical composition for treating thermatoid arthritis
GB1145623A (en) 1966-03-09 1969-03-19 Eustace Cecil Barton Wright Pharmaceutical composition
JPH10114652A (ja) 1996-10-15 1998-05-06 Dokutaazu Kosumeteikusu:Kk 津液改善剤及びそれを含有する経口投与用組成物
AU7222598A (en) * 1997-04-29 1998-11-24 Scotia Holdings Plc Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
FR2773484B1 (fr) * 1998-01-09 2001-03-30 Pierre Moreau Nouvelles compositions a effet synergique entre micronutriments et substances d'origine vivante
DE19844022C1 (de) 1998-09-25 2000-05-25 Sherif Sabry Ragab Mekkawi Verwendung von eisenbindenden Glycoproteinen und/oder 10-Hydroxy-2-decensäure in Verbindung mit Thymochinon zur Behandlung von AIDS
KR100886795B1 (ko) * 2000-06-01 2009-03-05 제이비에스 유나이티드, 인코포레이티드 동물 사료 및 방법
FR2825919B1 (fr) * 2001-06-14 2004-06-11 Oreal Utilisation d'au moins un derive de l'acide 10-hydroxy-2- decenoique dans des compositions destinees a traiter les signes cutanes du vieillissement
FR2829491B1 (fr) 2001-09-12 2005-09-30 Diverchim Procede de preparation des hydroxy-acides gras insatures et de leurs esters, leur utilisation comme agent anti-collagenase
MXPA04008711A (es) * 2002-03-08 2004-12-13 Monsanto Technology Llc Tratamiento y prevencion de trastornos inflamatorios.
JP4384981B2 (ja) 2002-09-06 2009-12-16 林原 健 精製ローヤルゼリー
JP2004131407A (ja) * 2002-10-09 2004-04-30 Yamada Bee Farm ローヤルゼリー又はその水溶性画分を有効成分とする抗うつ性組成物
JP4657778B2 (ja) 2004-03-30 2011-03-23 曽田香料株式会社 アラキドン酸代謝抑制剤
JP4727939B2 (ja) 2004-03-31 2011-07-20 アピ株式会社 低アレルゲン化ローヤルゼリーの製造方法
JP4579620B2 (ja) * 2004-08-25 2010-11-10 アピ株式会社 エストロゲン様作用剤及びその製造方法、並びに骨粗しょう症予防剤及び骨粗しょう症治療剤
CN1836671A (zh) 2005-03-21 2006-09-27 通化盛和药业股份有限公司 一种中药软胶囊及其制备方法和质量控制方法
FR2892410B1 (fr) 2005-10-21 2010-10-15 Fabre Pierre Dermo Cosmetique Nouveaux hydro-acides gras insatures et leur utilisation dermo cosmetologique
CA2632934A1 (en) * 2005-12-20 2007-07-05 Novozymes Biologicals, Inc. Surfactants systems for surface cleaning
AU2006330418B2 (en) * 2005-12-29 2010-07-15 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating inflammatory bowel disease
WO2007130581A2 (en) 2006-05-04 2007-11-15 Hardwicke Susan B Compositions and methods for psychiatric conditions and cognition enhancement
JP4749366B2 (ja) 2007-03-23 2011-08-17 株式会社山田養蜂場本社 ローヤルゼリー粉末からなる錠剤およびその製造方法
WO2009014105A1 (ja) 2007-07-20 2009-01-29 Yamada Apiculture Center, Inc. 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
JP2009274961A (ja) 2008-05-12 2009-11-26 Api Co Ltd 吸収促進剤
EP2311472B1 (en) * 2008-06-17 2014-03-05 Japan Royal Jelly Co., Ltd. Cognitive disorder-ameliorating agent
JP2010111646A (ja) * 2008-11-07 2010-05-20 Hayashibara Biochem Lab Inc 潰瘍性大腸炎治療剤
WO2013003689A2 (en) * 2011-06-30 2013-01-03 Nitromega Corp. Compositions containing nitro fatty acids
JP2010260833A (ja) * 2009-05-11 2010-11-18 Daicho Kikaku:Kk 抗自己免疫疾患剤
CN101570482B (zh) 2009-06-09 2012-12-26 李应阳 由ω-氯辛醇合成蜂王酸的方法
JP2012031153A (ja) * 2010-06-29 2012-02-16 Takara Bio Inc 脂肪燃焼促進剤
JP5770453B2 (ja) 2010-11-22 2015-08-26 八幡物産株式会社 ローヤルゼリー含有組成物及びソフトカプセル
JP5923699B2 (ja) * 2011-03-30 2016-05-25 アピ株式会社 老化防止剤
CN102408395B (zh) 2011-10-24 2014-04-02 广西师范大学 新的哌嗪和高哌嗪类衍生物及其制备方法和应用
WO2013066152A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Method for improving executive function
CA2866606C (en) * 2012-03-07 2022-03-15 Children's Medical Center Corporation Methods for enhancing, improving, or increasing fertility or reproductive function
EP2825065A1 (en) 2012-03-14 2015-01-21 Abbott Laboratories Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
US20140271844A1 (en) * 2013-03-15 2014-09-18 Nitromega Corp. Compositions containing nitro fatty acids

Also Published As

Publication number Publication date
EP3139741A4 (en) 2017-11-29
EP3139741A1 (en) 2017-03-15
US10004711B2 (en) 2018-06-26
TWI743022B (zh) 2021-10-21
CN106470547B (zh) 2020-10-09
US20170181995A1 (en) 2017-06-29
KR102399290B1 (ko) 2022-05-17
TW201622717A (zh) 2016-07-01
KR20170003637A (ko) 2017-01-09
JP2017514874A (ja) 2017-06-08
WO2015171960A1 (en) 2015-11-12
JP6819957B2 (ja) 2021-01-27
CN106470547A (zh) 2017-03-01

Similar Documents

Publication Publication Date Title
DK3134402T3 (da) 4-amino-imidazoquinolinforbindelser
DK3200886T3 (da) Spilsystem
DK3102669T3 (da) Forbedret bacillevært
BR112016023628A2 (pt) composições farmacêuticas.
KR20180084891A (ko) 구조 조성물 및 방법
DK3139769T3 (da) Næringsrige sammensætninger
MA40933A (fr) Difluorométhyl-aminopyridines et difluorométhyl-aminopyrimidines
DK3215173T3 (da) Glycopeptidsammensætninger
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3119396T3 (da) Muscarinreceptoragonister
DK3006072T3 (da) Karadgang
DK3110442T3 (da) Modificerede meningokok-fhbp-polypeptider
FR3024363B1 (fr) Composition thermogelifiable
DE112015001664A5 (de) Betätigungsaktuator
DK3099791T3 (da) Protein
BR112016026143A2 (pt) os métodos e composições compreendendo ácido 10-hidroxi-2-decenóico.
CL2017000639A1 (es) Composición
DK3110439T3 (da) Pcsk9-vacciner
DE112015005041A5 (de) Gargerätevorrichtung
DK3099793T3 (da) Protein
DK3229683T3 (da) Kapnometer
DK3200827T3 (da) Sammensætninger
FI20145972A (fi) Potkurisekoitin
DE102014000623A8 (de) Halbhohlnietelement
DK3233104T3 (da) Immunterapi-behandlinger og -sammensætninger

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: A01N 37/02

Ipc: A61K 31/20 (2006.01), A61K 31/202 (2006.01), A61P

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]